FindTrial
Sign In

Development of Real-time Blood Glucose Monitoring Technology Using Wireless Communication Techniques Without Fingerstick Blood Sampling

Real-Time Blood Glucose Monitoring by TeraHerz Wave Wireless Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008820
Enrollment
40
Registered
2023-09-22
Start date
2023-09-20
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We are planning to conduct a recruitment for a study involving 10 patients with type 2 diabetes who are visiting the Diabetes Center at Asan Medical Center in Seoul, along with 10 individuals with prediabetes and 20 individuals with normal blood glucose levels who are seeking medical attention for conditions other than glucose metabolism disorders.

Exclusion criteria

Exclusion criteria: Individuals with type 2 diabetes who are using insulin will be excluded from the study participants.

Design outcomes

Primary

MeasureTime frame
ChatGPT The study will assess the effectiveness of the terahertz wireless communication-based blood glucose measurement alongside venous glucose testing to determine the accuracy of the obtained glucose values.—

Countries

Korea, Republic of

Contacts

Public ContactChanghee Jung

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026